Cite
HARVARD Citation
Lewinter, C. et al. (2022). A systematic review and meta-analysis of beta-blockers and renin–angiotensin system inhibitors for preventing left ventricular dysfunction due to anthracyclines or trastuzumab in patients with breast cancer. European heart journal. pp. 2562-2569. [Online].